Consensus interferon: tailored therapy and the impact of adherence

Dig Dis Sci. 2011 Mar;56(3):631-4. doi: 10.1007/s10620-011-1563-8.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Age Factors
  • Antiviral Agents / therapeutic use*
  • Clinical Trials as Topic
  • Consensus Sequence
  • Drug Therapy, Combination
  • Hepacivirus / drug effects*
  • Hepatitis C / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects
  • Interferon-alpha / therapeutic use*
  • Liver Cirrhosis / drug therapy
  • Liver Cirrhosis / virology
  • Medication Adherence*
  • Polyethylene Glycols / adverse effects
  • Polyethylene Glycols / therapeutic use*
  • Recombinant Proteins
  • Ribavirin / therapeutic use*
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2b
  • peginterferon alfa-2a